
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Predicted Price is the pryogiTM prediction of where the price is going in next 3-4 quarters. There may be a revision of the predicted price every 3 months from the date of publication of the first predicted price of the stock. Price on Report Date is the price of the stock on the day prediction was published by pryogiTM. Current price shows the current price of the stock.
Margin of error shows range the price will end up in dollars either above or below the predicted price. Margin of error percentage shows the price will end up in percentage either above or below the predicted price.
Expected Returns from report date shows the returns (positive or negative) from published prediction date if you bought the stock on report date. Expected Returns from today shows the returns from today if you buy the stock today. A positive expected returns indicates a profit you will make, a negative expected return indicates a loss you will make if you buy the stock. There are different strategies to apply in the stock market for profit and loss, pryogiTM will publish such strategies in the future to help you.
PryogiTM meter shows you predicted price, price on the date this prediction was published(report date) and price of the stock today on a price scale. This indicates if the stock price is moving towards or away from the predicted price
PryogiTM performance chart shows actual movement of stock price from prediction published date(report date) and if the price is moving towards or away from predicted price
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Boston, April 04, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, "Bioprocess Optimization and Digital Bio-manufacturing: Global Markets" is expected to grow from $24.3 billion in 2024 to $39.6 billion by the end of 2029 at a compound annual growth rate ( CAGR ) of ...
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Proscia is rewiring pathology to speed up the development of targeted therapies, accelerate diagnosis, and match more patients with the best course of treatment Funding led by global software investor Insight Partners comes as the surge in cancer cases compounds the impact of the shrinking ...
Disclosed in the latest SEC filing, a significant insider purchase on March 18, involves Mala Anand, Director at Agilent Technologies A. What Happened: Anand's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday, involves purchasing 1,819 shares ...
A notable insider purchase on March 18, was reported by Otis W Brawley, Board Member at Agilent Technologies A, based on the most recent SEC filing. What Happened: Brawley's recent move, as outlined in a Form 4 filing with the U.S.
In a recent SEC filing, it was revealed that HEIDI FIELDS, Board Member at Agilent Technologies A, made a noteworthy insider purchase on March 18,. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that FIELDS purchased 1,819 shares of Agilent ...
Rockville, MD, March 11, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global breast cancer diagnostics market is estimated to reach a valuation of USD 6,389 million in 2025 and is expected to grow at a CAGR of 6.9% during the ...
Wilmington, Delaware, Transparency Market Research Inc. -, March 11, 2025 ( GLOBE NEWSWIRE ) -- The laboratory consumables market in Germany, Belgium, and the Netherlands is witnessing significant growth, fueled by rising R&D investments, technological advancements, and expanding biotech ...
David Kostin, the Chief U.S. Equity Strategist of Goldman Sachs, has revised his earnings growth forecast, citing a weaker economic outlook, and highlighted a shift in market trends. What Happened: On CNBC's 'Squawk on the Street', Kostin discussed his revised earnings growth forecast and market ...
Agilent Technologies's A short percent of float has fallen 8.53% since its last report. The company recently reported that it has 2.97 million shares sold short, which is 1.18% of all regular shares that are available for trading.
Delray Beach, FL, March 04, 2025 ( GLOBE NEWSWIRE ) -- The global microbiological testing of water market is projected to grow significantly, reaching an estimated $2.3 billion by 2027 at a compound annual growth rate ( CAGR ) of 7.4%.
Rockville, MD , March 04, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the Protection Reagents Market was valued at US$ 182.6 million in 2024 and is expected to grow at a CAGR of 5.5% during the forecast period of 2025 to 2035.
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
A's first-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns.
Agilent (A) delivered earnings and revenue surprises of 3.15% and 0.86%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
QSI's fourth-quarter performance is expected to have benefited from year-end capital spending and new product launches despite competition and stretched valuation.
Dan Loeb's Third Point cut its stake in Danaher and acquired 350,000 shares of Thermo Fisher in Q4 2024. Danaher shares fell ~10% YTD, while Thermo Fisher rose 0.66%, both underperforming the iShares U.S. Healthcare ETF.
A's fiscal first-quarter performance is likely to have been influenced by higher expenses, increased CapEx and the Lunar New Year timing shift.
Besides Wall Street's top -and-bottom-line estimates for Agilent (A), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended January 2025.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. B of A Securities analyst John Murphy upgraded the rating for Mobileye Global Inc.
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Agilent Technologies A has outperformed the market over the past 10 years by 2.63% on an annualized basis producing an average annual return of 13.78%. Currently, Agilent Technologies has a market capitalization of $42.12 billion.
Agilent Technologies's A short percent of float has risen 13.04% since its last report. The company recently reported that it has 3.29 million shares sold short, which is 1.3% of all regular shares that are available for trading.
US & Canada, Feb. 03, 2025 ( GLOBE NEWSWIRE ) -- According to a comprehensive report from The Insight Partners, "Microplate Reader Market Size and Forecast ( 2023 - 2031 ) , Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type ( Single-Mode Microplate ...
New York, United States, Jan. 23, 2025 ( GLOBE NEWSWIRE ) -- Spectrometry is used to investigate and measure a sample's spectrum. Atomic, mass, and molecular spectroscopy are examples. Spectroscopy studies how atoms absorb and release electromagnetic energy.
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Agilent Technologies's A short percent of float has fallen 8.0% since its last report. The company recently reported that it has 2.91 million shares sold short, which is 1.15% of all regular shares that are available for trading.
Agilent Technologies A has outperformed the market over the past 20 years by 1.62% on an annualized basis producing an average annual return of 10.13%. Currently, Agilent Technologies has a market capitalization of $42.45 billion.
New York, United States, Jan. 20, 2025 ( GLOBE NEWSWIRE ) -- A biopsy is a procedure where a small amount of tissue is extracted for examination under a microscope. In the case of a core biopsy, radiologists employ a needle to extract a sample from the lung tumor for diagnostic purposes.
Rockville, MD, Jan. 20, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global RNA transcriptome profiling test market is estimated to reach a valuation of US$ 9,652.2 million in 2024 and is expected to grow at a CAGR of 14.5% during ...
A faces challenges with slowing end-market demand and regulatory hurdles in China, raising growth concerns.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
PHILADELPHIA, Jan. 13, 2025 ( GLOBE NEWSWIRE ) -- Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, more than doubled its growth in 2024.
Rockville, MD, Jan. 08, 2025 ( GLOBE NEWSWIRE ) -- The global chromatography system market is estimated at US$ 1.39 billion in 2024 and is forecasted to expand at a CAGR of 6.6% from 2024 to 2034.
Agilent Technologies A has outperformed the market over the past 20 years by 1.21% on an annualized basis producing an average annual return of 9.61%. Currently, Agilent Technologies has a market capitalization of $38.96 billion.
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent Technologies A has outperformed the market over the past 10 years by 1.41% on an annualized basis producing an average annual return of 12.59%. Currently, Agilent Technologies has a market capitalization of $38.44 billion.
Investors need to pay close attention to Agilent (A) stock based on the movements in the options market lately.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Wilmington, Delaware, Transparency Market Research Inc. -, Dec. 10, 2024 ( GLOBE NEWSWIRE ) -- The global DNA polymerase market ( Mercado de la ADN polimerasa ) was valued at USD 137.0 Million in 2023 and is expected to expand at a CAGR of 6.2% between 2024 and 2034, reaching an estimated ...
A's shares ride on the bright performance of the Agilent CrossLab Group segment and strategic acquisitions.
Rockville, MD , Dec. 05, 2024 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global Cell-free DNA Mutation Diagnostics Market is estimated to reach a valuation of US$ 8,830.4 million in 2024 and is expected to grow at a CAGR of 24.9% ...
Westford, USA, Dec. 04, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that Newborn Screening Market size will attain the value of USD 2.12 Billion by 2031, with a CAGR of 6.8% during the forecast period ( 2024-2031 ) .
Examine Agilent's (A) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Wilmington, Delaware, Transparency Market Research Inc.:, Dec. 02, 2024 ( GLOBE NEWSWIRE ) -- The global oligonucleotides market ( mercado de oligonucleótidos ) is poised for significant growth, projected to expand at a robust CAGR of 11.9% from 2024 to 2034.
Westford, USA, Dec. 02, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Global Sample Preparation Market share will reach a value of USD 11446.67 Million by 2031, with a CAGR of 6.4% during the forecast period ( 2024-2031 ) .
Westford, USA, Nov. 29, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Global Preparative and Process Chromatography Market will attain a value of USD 24.15 Billion by 2031, with a CAGR of 11.7% during the forecast period ( 2024-2031 ) .
Westford, USA, Nov. 29, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the cell counting market size will attain a value of USD 17.72 billion by 2031, with a CAGR of 6.8% over the forecast period ( 2024-2031 ) .